HORSHAM, Pa.--(BUSINESS WIRE)--TargetRx, a pharmaceutical sales and marketing effectiveness company, today announced that it has been awarded a patent by the United States Patent and Trademark Office (U.S. Patent #7,080,027), titled “Method and System for Analyzing the Effectiveness of Marketing Strategies.” Demonstrating the company’s continued commitment to innovation, this newly patented method of predicting prescribing behavior allows TargetRx to provide highly actionable insights that help pharmaceutical companies improve sales and marketing performance.
